BACKGROUND: Convection-enhanced delivery (CED) permits site-specific therapeutic drug delivery within interstitial spaces at increased dosages through circumvention of the blood-brain barrier. CED is currently limited by suboptimal methodologies for monitoring the delivery of therapeutic agents that would permit technical optimization and enhanced therapeutic efficacy. OBJECTIVE: To determine whether a readily available small-molecule MRI contrast agent, gadolinium-diethylene triamine pentaacetic acid (Gd-DTPA), could effectively track the distribution of larger therapeutic agents. METHODS: Gd-DTPA was coinfused with the larger molecular tracer, I-labeled human serum albumin (I-HSA), during CED of an EGFRvIII-specific immunotoxin as part of treatment for a patient with glioblastoma. RESULTS: Infusion of both tracers was safe in this patient. Analysis of both Gd-DTPA and I-HSA during and after infusion revealed a high degree of anatomical and volumetric overlap. CONCLUSION: Gd-DTPA may be able to accurately demonstrate the anatomic and volumetric distribution of large molecules used for antitumor therapy with high resolution and in combination with fluid-attenuated inversion recovery (FLAIR) imaging, and provide additional information about leaks into cerebrospinal fluid spaces and resection cavities. Similar studies should be performed in additional patients to validate our findings and help refine the methodologies we used.
BACKGROUND: Convection-enhanced delivery (CED) permits site-specific therapeutic drug delivery within interstitial spaces at increased dosages through circumvention of the blood-brain barrier. CED is currently limited by suboptimal methodologies for monitoring the delivery of therapeutic agents that would permit technical optimization and enhanced therapeutic efficacy. OBJECTIVE: To determine whether a readily available small-molecule MRI contrast agent, gadolinium-diethylene triamine pentaacetic acid (Gd-DTPA), could effectively track the distribution of larger therapeutic agents. METHODS: Gd-DTPA was coinfused with the larger molecular tracer, I-labeled human serum albumin (I-HSA), during CED of an EGFRvIII-specific immunotoxin as part of treatment for a patient with glioblastoma. RESULTS: Infusion of both tracers was safe in this patient. Analysis of both Gd-DTPA and I-HSA during and after infusion revealed a high degree of anatomical and volumetric overlap. CONCLUSION: Gd-DTPA may be able to accurately demonstrate the anatomic and volumetric distribution of large molecules used for antitumor therapy with high resolution and in combination with fluid-attenuated inversion recovery (FLAIR) imaging, and provide additional information about leaks into cerebrospinal fluid spaces and resection cavities. Similar studies should be performed in additional patients to validate our findings and help refine the methodologies we used.
Authors: Y Mardor; Y Roth; Z Lidar; T Jonas; R Pfeffer; S E Maier; M Faibel; D Nass; M Hadani; A Orenstein; J S Cohen; Z Ram Journal: Cancer Res Date: 2001-07-01 Impact factor: 12.701
Authors: Dale Ding; Charles W Kanaly; Thomas J Cummings; James E Herndon; Raghu Raghavan; John H Sampson Journal: Neurol Res Date: 2009-12-21 Impact factor: 2.448
Authors: Steven S Gill; Nikunj K Patel; Gary R Hotton; Karen O'Sullivan; Renée McCarter; Martin Bunnage; David J Brooks; Clive N Svendsen; Peter Heywood Journal: Nat Med Date: 2003-03-31 Impact factor: 53.440
Authors: Peter M Grossi; Hidenobu Ochiai; Gary E Archer; Roger E McLendon; Michael R Zalutsky; Allan H Friedman; Henry S Friedman; Darell D Bigner; John H Sampson Journal: Clin Cancer Res Date: 2003-11-15 Impact factor: 12.531
Authors: Ryuta Saito; John R Bringas; Tracy R McKnight; Michael F Wendland; Christoph Mamot; Daryl C Drummond; Dmitri B Kirpotin; John W Park; Mitchel S Berger; Krys S Bankiewicz Journal: Cancer Res Date: 2004-04-01 Impact factor: 12.701
Authors: Jiangbing Zhou; Kofi-Buaku Atsina; Benjamin T Himes; Garth W Strohbehn; W Mark Saltzman Journal: Cancer J Date: 2012 Jan-Feb Impact factor: 3.360
Authors: Martin L Brady; Raghu Raghavan; Jaime Mata; Mike Wilson; Scott Wilson; Rick M Odland; William C Broaddus Journal: Stereotact Funct Neurosurg Date: 2018-07-18 Impact factor: 1.875
Authors: Marco Antônio Peliky Fontes; Gisele Cristiane Vaz; Thais Zielke Dias Cardoso; Mariana Flávia de Oliveira; Maria José Campagnole-Santos; Robson Augusto Souza Dos Santos; Neeru M Sharma; Kaushik P Patel; Frédéric Frézard Journal: Nanomedicine Date: 2017-12-24 Impact factor: 5.307
Authors: Annick Desjardins; Matthias Gromeier; James E Herndon; Nike Beaubier; Dani P Bolognesi; Allan H Friedman; Henry S Friedman; Frances McSherry; Andrea M Muscat; Smita Nair; Katherine B Peters; Dina Randazzo; John H Sampson; Gordana Vlahovic; William T Harrison; Roger E McLendon; David Ashley; Darell D Bigner Journal: N Engl J Med Date: 2018-06-26 Impact factor: 91.245